Published in Nutr Metab Cardiovasc Dis on September 27, 2012
Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr (2015) 2.10
Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. Am J Clin Nutr (2014) 1.47
Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia (2014) 1.26
Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med (2014) 1.17
Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One (2013) 1.10
Dairy products consumption and metabolic syndrome in adults: systematic review and meta-analysis of observational studies. Sci Rep (2015) 0.84
Dairy consumption and the risk of 15-year cardiovascular disease mortality in a cohort of older Australians. Nutrients (2013) 0.81
Dairy products and prevention of type 2 diabetes: implications for research and practice. Front Endocrinol (Lausanne) (2013) 0.81
Dairy foods and dairy proteins in the management of type 2 diabetes: a systematic review of the clinical evidence. Adv Nutr (2015) 0.80
Adult lactose digestion status and effects on disease. Can J Gastroenterol Hepatol (2015) 0.79
Milk, dairy products, and their functional effects in humans: a narrative review of recent evidence. Adv Nutr (2014) 0.79
Associations between dairy food consumption and chronic kidney disease in older adults. Sci Rep (2016) 0.75
Systematic Review of the Association between Dairy Product Consumption and Risk of Cardiovascular-Related Clinical Outcomes. Adv Nutr (2016) 0.75
Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc (1966) 17.89
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82
Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09
Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J (1999) 5.68
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology (1996) 5.36
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases. Genes Dev (1999) 4.95
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers. Biochem J (1967) 4.24
Proton-coupled beta-galactoside translocation in non-metabolizing Escherichia coli. J Bioenerg (1972) 4.24
Estimation of membrane potential and pH difference across the cristae membrane of rat liver mitochondria. Eur J Biochem (1969) 3.97
Translocations through natural membranes. Adv Enzymol Relat Areas Mol Biol (1967) 3.77
Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: power transmission by proticity. Biochem Soc Trans (1976) 3.58
Cooperative hernia study. Pain in the postrepair patient. Ann Surg (1996) 3.57
Possible molecular mechanisms of the protonmotive function of cytochrome systems. J Theor Biol (1976) 3.41
Performance and conservation of osmotic work by proton-coupled solute porter systems. J Bioenerg (1973) 3.41
Keilin's respiratory chain concept and its chemiosmotic consequences. Science (1979) 3.23
Translocation of some anions cations and acids in rat liver mitochondria. Eur J Biochem (1969) 3.13
The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins. Genes Dev (1994) 3.12
Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07
Chemiosmotic coupling in energy transduction: a logical development of biochemical knowledge. J Bioenerg (1972) 3.02
Proton-translocation phosphorylation in mitochondria, chloroplasts and bacteria: natural fuel cells and solar cells. Fed Proc (1967) 2.96
Proton/sodium ion antiport in Escherichia coli. Biochem J (1974) 2.89
Prevalence and causes of amblyopia in an adult population. Ophthalmology (1998) 2.84
Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77
The polarity of proton translocation in some photosynthetic microorganisms. Eur J Biochem (1969) 2.74
Stoicheiometry of lactose-H+ symport across the plasma membrane of Escherichia coli. Biochem J (1973) 2.57
Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc (1998) 2.51
Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res (2000) 2.47
Acid-base titration across the plasma membrane of Micrococcus denitrificans: factors affecting the effective proton conductance and the respiratory rate. J Bioenerg (1970) 2.45
Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J (2006) 2.34
The protonmotive Q cycle: a general formulation. FEBS Lett (1975) 2.32
Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology (1999) 2.29
"Smoking is a major cause of blindness". Med J Aust (1999) 2.27
The Ninth Sir Hans Krebs Lecture. Compartmentation and communication in living systems. Ligand conduction: a general catalytic principle in chemical, osmotic and chemiosmotic reaction systems. Eur J Biochem (1979) 2.25
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia (2010) 2.23
Stoichiometry of proton translocation through the respiratory chain and adenosine triphosphatase systems of rat liver mitochondria. Nature (1965) 2.19
Respiration-driven proton translocation in Micrococcus denitrificans. J Bioenerg (1971) 2.17
Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol (2009) 2.13
Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett (1975) 2.07
Knowledge and beliefs about common eye diseases. Aust N Z J Ophthalmol (1997) 2.06
Medications and cataract. The Blue Mountains Eye Study. Ophthalmology (1998) 2.05
Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol (2001) 2.00
Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol (2008) 1.98
British Medical Association enters GM-crop affray. Lancet (1999) 1.94
Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93
Clustering of modified nucleotides at the functional center of bacterial ribosomal RNA. FASEB J (1993) 1.93
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care (2001) 1.84
Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol (1998) 1.84
Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82
Retinopathy predicts coronary heart disease mortality. Heart (2008) 1.80
The development of performance and cost indicators for preschool immunisation. Arch Dis Child (1986) 1.77
Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol (1998) 1.70
Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (1999) 1.70
Propofol and ECT. Br J Psychiatry (1992) 1.68
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 1.67
Vectorial chemiosmotic processes. Annu Rev Biochem (1977) 1.66
Incidence of nursing home placement in a defined community. Med J Aust (2001) 1.65
The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64
The nature of bipolar depression: implications for the definition of melancholia. J Affect Disord (2000) 1.64
Effects of cataract type and location on visual function: the Blue Mountains Eye Study. Eye (Lond) (2004) 1.62
Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms. Br J Surg (1983) 1.59
Covered expandable tracheal stents in the management of benign tracheal granulation tissue formation. Ann Thorac Surg (2000) 1.59
Proton translocation coupled to ATP hydrolysis in rat liver mitochondria. Eur J Biochem (1968) 1.57
Visual impairment, age-related cataract, and mortality. Arch Ophthalmol (2001) 1.55
Dairy consumption and overweight and obesity: a systematic review of prospective cohort studies. Obes Rev (2011) 1.54
Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol (1998) 1.53
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Renal impairment and anaemia in a population-based study of older people. Intern Med J (2004) 1.51
Cystadenomas of the liver: a spectrum of disease. Can J Surg (2001) 1.51
Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology (2011) 1.49
The role of smart cards in France. Health Data Manag (1998) 1.49
Synthesis of adenosine triphosphate by a protonmotive force in rat liver mitochondria. Nature (1966) 1.48
Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol (1999) 1.48
Chemiosmotic hypothesis of oxidative phosphorylation. Nature (1967) 1.47
Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol (2000) 1.45
Study of cardiac rhythm in healthy newborn infants. Br Heart J (1980) 1.43
Does intra-arterial thrombolysis have a role as first-line intervention in acute ischaemic stroke? Intern Med J (2011) 1.43
Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma. Mol Imaging Biol (2009) 1.42
Consequences of amblyopia on education, occupation, and long term vision loss. Br J Ophthalmol (2004) 1.42
The proton-translocating ATPase of Escherichia coli. FEBS Lett (1974) 1.41
Posttransplant cataract: lessons from kidney-pancreas transplantation. Transplantation (2000) 1.41
Decompressive craniectomy in traumatic brain injury: the randomized multicenter RESCUEicp study (www.RESCUEicp.com). Acta Neurochir Suppl (2006) 1.41
Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy. Aust N Z J Psychiatry (1992) 1.40
Crash and boom: the rise and fall of biotechnology. Lancet (1997) 1.40
Struggle worldwide to regain consumers' faith in food. Lancet (1997) 1.40
Neural network subtyping of depression. Aust N Z J Psychiatry (1998) 1.39
Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial. Int J Clin Pract (2009) 1.39
Methylation sites in Escherichia coli ribosomal RNA: localization and identification of four new sites of methylation in 23S rRNA. Biochemistry (1992) 1.39
Refractive associations with cataract: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (1999) 1.38
Depression sub-typing: unitary, binary or arbitrary? Aust N Z J Psychiatry (1991) 1.38
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
Evidence discriminating between the chemical and the chemiosmotic mechanisms of electron transport phosphorylation. Nature (1965) 1.37
Embolic occlusion of the blood supply to uterine myomas: report of 2 cases. Aust N Z J Obstet Gynaecol (1999) 1.37
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers (2009) 1.37